down arrow

Emmessar Biotech

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE634B01016
  • NSEID:
  • BSEID: 524768
INR
29.20
0.15 (0.52%)
BSENSE

Dec 05

BSE+NSE Vol: 3.96 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Emmessar Biotech & Nutrition Ltd stock-summary
stock-summary
Emmessar Biotech & Nutrition Ltd
Micro Cap
Commodity Chemicals
Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
Company Coordinates stock-summary
Company Details
Plot No T-3/2 MIDC Area, P O Box No 39 Taloja Raigad Maharashtra : 410208
stock-summary
Tel: 91-022-20870587
stock-summary
http://www.ebnl.co.in
stock-summary
investors@ebnl.co.in/emmessar@vsnl.
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.05%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Emmessar Technologies Limited (21.79%)

Highest Public shareholder

Sandeep Rao (2.04%)

Individual Investors Holdings

38.12%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
MSR Ayyangar
Chairman & Managing Director
19.03 lacs
Anuradha Raghavan
Non Executive Director
0
Sarada Raghavan
Non Executive Director
0
Anantharama Sethmani Subramanian
Independent Director
0
Jayavel Balaiah Nadar
Executive Director & CFO
10.02 lacs
Rajalakshmi Srinivasa Raghavan
Non Executive Director
0
Priyanka Omprakash Sharma
Company Sec. & Compli. Officer
0
Milind S Desai
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Healthcare Products - Traded
0.35
56.34%
Healthcare Products
0.16
25.31%
 
56.34
Healthcare Products - Traded
43.66
Healthcare Products - Traded
25.31
Healthcare Products
74.69
Healthcare Products
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 15 Cr (Micro Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.92

stock-summary
Return on Equity

2.88%

stock-summary
Price to Book

1.85

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."